Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD9 | Q9H8M2 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL940333 | 0.78 | TUBB4A (0.44) | BRD9CYP2C9GAAALDH1A1PTGS2 | |
| SCHEMBL27899616 | 0.71 | MEN1 (0.39) | BRD9CYP2C9ALDH1A1PDE4BPTGS2 | |
| SCHEMBL941849 | 0.71 | CYP2C9 (0.53) | BRD9CYP2C9GAAMAPK1MAPT | |
| SCHEMBL9042497 | 0.69 | P2RX7 (0.42) | GAAMAPTALDH1A1KDM4EMEN1 | |
| SCHEMBL4026631 | 0.69 | ACHE (0.39) | MAPTALDH1A1KDM4EDHFR | |
| SCHEMBL30958058 | 0.69 | ACHE (0.39) | MAPTALDH1A1KDM4EDHFR | |
| SCHEMBL25656907 | 0.68 | ALDH1A1 (0.57) | MAPTALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL12806668 | 0.68 | ALDH1A1 (0.61) | MAPTALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL10562175 | 0.67 | CYP2C9 (0.43) | BRD9CYP2C9ALDH1A1KDM4EMEN1 | |
| SCHEMBL13347571 | 0.67 | NOTUM (0.46) | MAPK1MAPTALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015403-A1 | PROCESS FOR PREPARING IODINATED AZOLES | LANXESS DEUTSCHLAND GMBH (DE) | 2011-01-20 | — | — | US | disclosed |
| EP-1979333-A1 | PROCESS FOR PREPARING IODINATED AZOLES | Lanxess Deutschland GmbH (DE) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007085349-A1 | PROCESS FOR PREPARING IODINATED AZOLES | LANXESS DEUTSCHLAND GMBH (DE) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015403-A1 | PROCESS FOR PREPARING IODINATED AZOLES | AZI2, TPO, INSR | BRD9 162/4885CYP2C9 230/4885GAA 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.